10. April 2012

Posted in: FDA Alerts and Warnings

Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots

Women should talk to their healthcare professional about their risk for blood clots before deciding which birth control method to use.
Continue reading...

4. April 2012

Posted in: FDA Alerts and Warnings

Thoratec Corporation, HeartMate II Left Ventricular Assist System (LVAS): Class 1 Recall- Outflow Graft May Kink or Deform

May result in reduction of blood flow from the pump, pump/graft thrombosis, or perforation of the outflow graft.
Continue reading...

3. April 2012

Posted in: FDA Alerts and Warnings

Altuzan (bevacizumab): Counterfeit Product – Contains no Active Ingredient

The counterfeit product may have resulted in patients not receiving needed therapy.
Continue reading...

23. March 2012

Posted in: FDA Alerts and Warnings

Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall – Potential for Visible Particulates

Risk of embolization/infarction to organs and potential organ complications.
Continue reading...

15. March 2012

Posted in: FDA Alerts and Warnings

Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury

Products with this toxic metal have been found in at least seven states, are manufactured abroad and often sold in shops in Latino, Asian, African or Middle Eastern neighborhoods and online.
Continue reading...

13. March 2012

Posted in: FDA Alerts and Warnings

Acclarent Inspira AIR Balloon Dilation System: Class 1 Recall – Potential For Balloon To Not Deflate Or To Deflate To Slowly

Prolonged obstruction of the airway may prevent adequate blood oxygenation, which could cause temporary or permanent impairment to the patient.
Continue reading...

2. March 2012

Posted in: FDA Alerts and Warnings

Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators (AEDs): Class I Recall – Defective Component

Unexpected component failure may lead to AEDs not delivering defibrillation therapy, causing serious adverse health consequences, including death.
Continue reading...

1. March 2012

Posted in: FDA Alerts and Warnings

Statins and HIV or Hepatitis C Drugs: Drug Safety Communication – Interaction Increases Risk of Muscle Injury

Protease inhibitors and statins taken together may raise the blood levels of statins and increase the risk of myopathy, kidney damage, and kidney failure, which can be fatal.
Continue reading...
PHVsPjwvdWw+